Growth Metrics

Merck (MRK) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $2.6 billion.

  • Merck's Cash from Financing Activities rose 20878.35% to $2.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 billion, marking a year-over-year decrease of 5446.71%. This contributed to the annual value of -$7.0 billion for FY2024, which is 4619.54% down from last year.
  • Latest data reveals that Merck reported Cash from Financing Activities of $2.6 billion as of Q3 2025, which was up 20878.35% from -$3.6 billion recorded in Q2 2025.
  • Over the past 5 years, Merck's Cash from Financing Activities peaked at $5.2 billion during Q4 2021, and registered a low of -$5.8 billion during Q1 2025.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$2.2 billion (2023), whereas its average is -$1.3 billion.
  • As far as peak fluctuations go, Merck's Cash from Financing Activities skyrocketed by 31148.0% in 2023, and later plummeted by 39243.42% in 2025.
  • Over the past 5 years, Merck's Cash from Financing Activities (Quarter) stood at $5.2 billion in 2021, then tumbled by 129.84% to -$1.6 billion in 2022, then plummeted by 44.47% to -$2.2 billion in 2023, then crashed by 34.03% to -$3.0 billion in 2024, then skyrocketed by 187.67% to $2.6 billion in 2025.
  • Its last three reported values are $2.6 billion in Q3 2025, -$3.6 billion for Q2 2025, and -$5.8 billion during Q1 2025.